Breaking News, Financial News

Financial Report: Patheon 2Q12

CMO revenues up 6% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon   2Q Revenues: $181.5 million (+7%)   2Q Loss: $79.7 million (loss of $10.4 million in 2Q11)   YTD Revenues: $335.4 million  (-3%)   YTD Loss: $99.1 million (loss of $6.8 million YTD11)   Comments: Commercial manufacturing revenues for the quarter increased 6% to $147.0 million. Pharmaceutical Development Services revenues were up 10% to $34.5 million due to increased development activities from new contracts across most sites. Loss in the quarter increased due to the after-tax impact o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters